$313 Million Settlement reached in Whistleblower case with Forest Pharmaceuticals Inc

Settlement Amount: 

A settlement has been reached in a whistleblower class action lawsuit brought against Forest Pharmaceuticals Inc  accused of submitting fraudulent claims to federal health care programs for the drugs Levothroid, Celexa, and Lexapro.


The settlement covers various whistleblower lawsuits filed under the provisions of the False Claims Act.   As part of the civil settlement, more than $88 million will be distributed to the federal government and more than $60 million will be distributed to and shared by the states.   Additionally, the private whistleblowers will receive approximately $14 million from the federal share of the settlement amount.  

The Justice Department alleged Forest's fradulent activity took place from 1998 until at least 2005.

If you have a similar case please fill out the form below or email mail@whistleblowerinstitute.com or call: 619-452–1218


If you or someone you know experienced a similar situation or any other wrongdoing within a corporation you should contact mail@whistleblowerinstitute.com or call: 619-452–1218

Go to top